Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

NIH Study Finds Regular Aspirin Use May Reduce Ovarian Cancer Risk

National Cancer Institute (NCI) at NIH

Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical recommendations can be made.

Channels: Cancer, All Journal News,

Released:
6-Feb-2014 4:00 PM EST
Open in New Tab
Comment

Adding Chemotherapy Following Radiation Treatment Improves Survival for Adults with a Slow-Growing Type of Brain Tumor

National Cancer Institute (NCI) at NIH

Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.

Channels: Cancer,

Released:
5-Feb-2014 8:50 AM EST
Open in New Tab
Comment
Research Results

NCI Launches Trial to Assess the Utility of Genetic Sequencing to Improve Patient Outcomes

National Cancer Institute (NCI) at NIH

A pilot trial to assess whether assigning treatment based on specific gene mutations can provide benefit to patients with metastatic solid tumors is being launched this month by the National Cancer Institute (NCI), part of the National Institutes of Health.

Channels: Cancer,

Released:
30-Jan-2014 2:00 PM EST
Open in New Tab
Comment
Research Results

TCGA Bladder Cancer Study Reveals Potential Drug Targets, Similarities to Several Cancers

National Cancer Institute (NCI) at NIH

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease.

Channels: Cancer, All Journal News,

Released:
29-Jan-2014 2:00 PM EST
Open in New Tab
Comment
Feature
Newswise: NIH Scientists Map Genetic Changes That Drive Tumors in a Common Pediatric Soft-Tissue Cancer

NIH Scientists Map Genetic Changes That Drive Tumors in a Common Pediatric Soft-Tissue Cancer

National Cancer Institute (NCI) at NIH

Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes.

Channels: Cancer, All Journal News,

Released:
24-Jan-2014 10:30 AM EST
Open in New Tab
Comment
Research Results
Newswise: Lung Cancer Death Rates Continue to Fall, Helping Drive Ongoing Decrease in Overall Cancer Death Rates

Lung Cancer Death Rates Continue to Fall, Helping Drive Ongoing Decrease in Overall Cancer Death Rates

National Cancer Institute (NCI) at NIH

The Annual Report to the Nation on the Status of Cancer, covering the period 1975–2010, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years.

Channels: Cancer, All Journal News,

Released:
16-Dec-2013 10:45 AM EST
Open in New Tab
Comment
Research Results
Newswise: NIH-Funded Study Shows Increased Survival in Men with Metastatic Prostate Cancer Who Receive Chemotherapy When Starting Hormone Therapy

NIH-Funded Study Shows Increased Survival in Men with Metastatic Prostate Cancer Who Receive Chemotherapy When Starting Hormone Therapy

National Cancer Institute (NCI) at NIH

Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.

Channels: Cancer, Men's Health,

Released:
11-Dec-2013 3:00 PM EST
Open in New Tab
Comment
Research Results

New Studies Demonstrate That Modified T Cells Are Effective in Treating Blood-Borne Cancers

National Cancer Institute (NCI) at NIH

At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., investigator in the Experimental Transplantation and Immunology Branch, NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.

Channels: Cancer, Medical Meetings,

Released:
11-Dec-2013 3:00 PM EST
Open in New Tab
Comment
Research Results
Newswise: NIH Mouse Study Finds Gut Microorganisms May Determine Cancer Treatment Outcome

NIH Mouse Study Finds Gut Microorganisms May Determine Cancer Treatment Outcome

National Cancer Institute (NCI) at NIH

An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI).

Channels: Cancer,

Released:
21-Nov-2013 2:00 PM EST
Open in New Tab
Comment
Research Results

Worldwide Trends Show Oropharyngeal Cancer Rates Increasing

National Cancer Institute (NCI) at NIH

NCI scientists report that the incidence of oropharyngeal cancer significantly increased during the period 1983-2002 among people in countries that are economically developed.

Channels: Cancer, All Journal News,

Released:
21-Nov-2013 11:00 AM EST
Open in New Tab
Comment
Research Results


0.60792